Physician

Kevin C Chen, MD

According to 2025 Medicare claims, Kevin Chen, MD (NPI: 1447518832) practices ophthalmology in the Salinas, CA market, with the plurality of this provider's patient population coming from Monterey, CA. This provider's primary affiliated billing organization is VANTAGE EYE CENTER A MEDICAL CORP (NPI: 1588765903; TIN: 94-2720020) and primary practice location at 93901-4315.

Chen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,882 traditional Medicare patients, billed 19,824 HCPCS/CPT codes, and received $2,404,658 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 324 prescription claims across 147 beneficiaries totaling $28,851 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 3 records totaling $169. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $7,579 to $2,404,658. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $21,527 and ending at $28,851. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2016 Medicare payment: $7,579 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $68,072 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $268,237 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $743,124 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $923,596 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,084,153 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,188,941 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,850,586 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,404,658 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201653138$7,579
2017193752$68,072
20181,0882,886$268,237
20191,7878,159$743,124
20201,4979,202$923,596
20211,6069,290$1,084,153
20221,6258,289$1,188,941
20231,84512,184$1,850,586
20241,88219,824$2,404,658

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$20K$39K2015 Drug cost: $21,527 (USD; Tot_Drug_Cst)2016 Drug cost: $9,653 (USD; Tot_Drug_Cst)2018 Drug cost: $10,157 (USD; Tot_Drug_Cst)2019 Drug cost: $39,217 (USD; Tot_Drug_Cst)2020 Drug cost: $26,895 (USD; Tot_Drug_Cst)2021 Drug cost: $22,150 (USD; Tot_Drug_Cst)2022 Drug cost: $19,170 (USD; Tot_Drug_Cst)2023 Drug cost: $27,122 (USD; Tot_Drug_Cst)2024 Drug cost: $28,851 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201582339$21,527
201645159$9,653
2017N/RN/RN/R
201877158$10,157
2019174395$39,217
2020116348$26,895
2021108315$22,150
2022103243$19,170
2023108255$27,122
2024147324$28,851

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system1,3491,619$90
67028Injection of drug into eye3491,536$90
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more401784$76
92012Established patient problem focused exam of visual system410834$61
92134Imaging of retina1,7573,302$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine13450$9,482
TobradexTobramycin/Dexamethasone18204$4,659
Prednisolone AcetatePrednisolone Acetate822,219$2,642
Flurbiprofen SodiumFlurbiprofen Sodium15343$712
OfloxacinOfloxacin48935$556

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$169Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kevin C. Chen, MD?

Tedicare shows public-source Medicare data for Kevin C. Chen, MD (NPI 1447518832), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin C. Chen, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kevin C. Chen, MD?

Kevin C. Chen, MD is linked to VANTAGE EYE CENTER A MEDICAL CORP (billing NPI 1588765903) in the available physician profile data.

Does Kevin C. Chen, MD have Open Payments data?

Kevin C. Chen, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.